secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001641172-25-020209
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix shareholders approve reverse stock split with 1:2 to 1:50 range
----------------------------------------------------------------------------

- Reverse stock split amendment approved: ratio of 1-for-2 to 1-for-50, at Board discretion, within one year.
- Votes: 550,179 for, 183,224 against, 33,836 abstentions.
- Adjournment proposal approved (573,509 for, 166,066 against) but not needed.
- Special meeting held July 17, 2025; previously adjourned from July 11.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/0001641172-25-020209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer